| Online-Ressource |
Verfasst von: | Loganathan, Sivakkanan [VerfasserIn]  |
| Korkmaz-İçöz, Sevil [VerfasserIn]  |
| Radovits, Tamás [VerfasserIn]  |
| Li, Shiliang [VerfasserIn]  |
| Mikles, Beatrice [VerfasserIn]  |
| Barnucz, Enikő [VerfasserIn]  |
| Hirschberg, Kristóf [VerfasserIn]  |
| Karck, Matthias [VerfasserIn]  |
| Szabó, Gábor [VerfasserIn]  |
Titel: | Effects of soluble guanylate cyclase activation on heart transplantation in a rat model |
Verf.angabe: | Sivakkanan Loganathan, MD, Sevil Korkmaz-Icöz, PhD, Tamás Radovits, MD, PhD, Shiliang Li, MD, Beatrice Mikles, EnikőBarnucz, MD, Kristóf Hirschberg, MD, PhD, Matthias Karck, MD, and Gábor Szabó, MD, PhD |
E-Jahr: | 2015 |
Jahr: | 11 June 2015 |
Umfang: | 8 S. |
Fussnoten: | Gesehen am 02.06.2020 |
Titel Quelle: | Enthalten in: The journal of heart and lung transplantation |
Ort Quelle: | Amsterdam [u.a.] : Elsevier Science, 1999 |
Jahr Quelle: | 2015 |
Band/Heft Quelle: | 34(2015), 10, Seite 1346-1353 |
ISSN Quelle: | 1557-3117 |
Abstract: | Background - The nitric oxide (NO)/soluble guanylate cyclase (sGC)/cyclic guanosine monophosphate (cGMP) pathway is an important key mechanism to protect the heart from ischemia/reperfusion injury. However, this pathway is disrupted in several cardiovascular diseases as a result of decreased NO bioavailability and increased NO-insensitive forms of sGC. Cinaciguat preferentially activates these NO-insensitive, oxidized forms of sGC. - Methods - We assessed the hypothesis that targeting NO-unresponsive sGC would protect the graft against ischemia/reperfusion injury in a rat heart transplantation model. Before explantation, donor Lewis rats received methylcellulose (1%) vehicle or cinaciguat 10 mg/kg. The hearts were excised, stored in cold preservation solution, and heterotopically transplanted. We evaluated in vivo left ventricular function of the graft. - Results - After transplantation, decreased left ventricular systolic pressure (77 ± 3 mm Hg vs 123 ± 13 mm Hg, p < 0.05), dP/dtmax (1,703 ± 162 mm Hg vs 3,350 ± 444 mm Hg, p < 0.05), and dP/dtmin (995 ± 110 mm Hg vs 1,925 ± 332 mm Hg, p < 0.05) were significantly increased by cinaciguat. Coronary blood flow was significantly higher in the cinaciguat group compared with the control group. Additionally, cinaciguat increased adenosine triphosphate levels (1.9 ± 0.4 µmol/g vs 6.6 ± 0.8 µmol/g, p < 0.05) and improved energy charge potential. After transplantation, increased c-jun messenger RNA expression was downregulated, whereas superoxide dismutase-1 and cytochrome-c oxidase mRNA levels were upregulated by cinaciguat. Cinaciguat also significantly decreased myocardial DNA strand breaks induced by ischemia/reperfusion during transplantation and reduced death of cardiomyocytes in a cellular model of oxidative stress. - Conclusions - By interacting with NO-unresponsive sGC, cinaciguat enhances the protective effects of the NO/cGMP pathway at different steps of signal transduction after global myocardial ischemia/reperfusion. Its clinical use as pre-conditioning agent could be a novel approach in cardiac surgery. |
DOI: | doi:10.1016/j.healun.2015.05.006 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: https://doi.org/10.1016/j.healun.2015.05.006 |
| Volltext: http://www.sciencedirect.com/science/article/pii/S1053249815012772 |
| DOI: https://doi.org/10.1016/j.healun.2015.05.006 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | cinaciguat |
| heart transplantation |
| ischemia/reperfusion |
| nitric oxide |
| soluble guanylate cyclase |
| soluble guanylate cyclase activation |
K10plus-PPN: | 1699158355 |
Verknüpfungen: | → Zeitschrift |
Effects of soluble guanylate cyclase activation on heart transplantation in a rat model / Loganathan, Sivakkanan [VerfasserIn]; 11 June 2015 (Online-Ressource)